Will These Nuances Undo Merck And Moderna's Cancer Vaccine?
Will These Nuances Undo Merck And Moderna's Cancer Vaccine? Investor's Business Daily
Covered in this story
Analyst targets on Moderna
- Citi: $193 → $80 by Sep 2027 · Sell via 247wallst.com
- Rothschild & Co Redburn: $149 → $81 by Sep 2027 · Sell via Investing.com
- Morgan Stanley: $174 → $89 by Aug 2027 · Equalweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Moderna →Dalsna Finance is currently tracking 15 stories mentioning Moderna, the earliest published 20 Oct 2026.
Summary aggregated from Investor's Business Daily's public RSS feed. The full reporting belongs to Investor's Business Daily — please read it on their site.